Recombinant full length protein, corresponding to amino acids 1-395 of Human NDRG1
Abcam is committed to meeting high standards of ethical manufacturing and has decided to discontinue this product by July 2018 as it has been generated by the ascites method. We are sorry for any inconvenience this may cause.
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 1 - 5 µg/ml.
Use 0.5µg for 106 cells. ab170191-Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.
May have a growth inhibitory role.
Ubiquitous; expressed most prominently in placental membranes and prostate, kidney, small intestine, and ovary tissues. Reduced expression in adenocarcinomas compared to normal tissues. In colon, prostate and placental membranes, the cells that border the lumen show the highest expression.
Defects in NDRG1 are the cause of Charcot-Marie-Tooth disease type 4D (CMT4D) [MIM:601455]; also known as hereditary motor and sensory neuropathy Lom type (HMSNL). CMT4D is a recessive form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy and primary peripheral axonal neuropathy. Demyelinating CMT neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention, autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.
Belongs to the NDRG family.
Cytoplasm. Nucleus. Cell membrane. Whereas in prostate epithelium and placental chorion it is located in both the cytoplasm and the nucleus, nuclear staining is not observed in colon epithelium cells. Instead its localization changes from the cytoplasm to the plasma membrane during differentiation of colon carcinoma cell lines in vitro.
N myc downstream regulated gene 1 protein antibody
N-myc downstream-regulated gene 1 protein antibody
Ndr 1 antibody
NDRG 1 antibody
NDRG1 protein antibody
Nickel specific induction protein antibody
Nickel specific induction protein Cap43 antibody
Nickel-specific induction protein Cap43 antibody
Nmyc downstream regulated antibody
Nmyc downstream regulated gene1 antibody
Nmyc downstream regulated gene1 protein antibody
Protein NDRG1 antibody
Protein regulated by oxygen 1 antibody
Protein regulated by oxygen1 antibody
Reduced in tumor antibody
Reducing agents and tunicamycin responsive protein antibody
Reducing agents and tunicamycin-responsive protein antibody
Tunicamycin responsive protein antibody
Western blot - NDRG1 antibody (ab56697)
Western blot against tagged recombinant protein immunogen using ab56697 NDRG1 antibody at 1ug/ml. Predicted band size of immunogen is 69 kDa
Flow Cytometry - Anti-NDRG1 antibody (ab56697)
Overlay histogram showing Caco-2 cells stained with ab56697 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab56697, 0.5µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
Antrobus R et al. Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome. Proteomics9:3913-27 (2009).
Read more (PubMed: 19670248) »